FDA Warns About Chikungunya Vaccine

Redacted is an independent platform, unencumbered by external factors or restrictive policies, on which Clayton and Natali Morris bring you quality information, balanced reporting, constructive debate, and thoughtful narratives. Stay informed by visiting Redacted for the latest insights.

The Food and Drug Administration (FDA) is warning adults over 60 not to get the chikungunya vaccine after two patients died.

What is chikungunya virus? It is a mosquito-borne virus much like Zika and dengue, more common in tropical areas.

The FDA reports that it found at least “17 serious adverse events, including two that resulted in death, in individuals 62 through 89 years of age” from the vaccine brandnamed IXCHIQ.

The vaccine contains the chikungunya virus so the people who had the vaccine died from the symptoms of the very virus they were trying NOT to get.

The vaccine was clinically trialed on 3,500 people over the age of 18 but if participants reacted this poorly, it wasn’t disclosed to the public.

Related Articles

Join the Redacted Community

Don’t miss out on the latest news and in-depth stories. Subscribe to Redacted newsletter for daily insights that matter, delivered directly to your inbox.

Related Articles